Venture Visionary Partners LLC Has $4.63 Million Position in Tempus AI, Inc. $TEM

Venture Visionary Partners LLC increased its holdings in shares of Tempus AI, Inc. (NASDAQ:TEM) by 305.2% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 57,368 shares of the company’s stock after purchasing an additional 43,211 shares during the period. Venture Visionary Partners LLC’s holdings in Tempus AI were worth $4,630,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in TEM. PNC Financial Services Group Inc. increased its stake in Tempus AI by 707.5% during the first quarter. PNC Financial Services Group Inc. now owns 4,716 shares of the company’s stock valued at $228,000 after acquiring an additional 4,132 shares during the period. Vanguard Group Inc. lifted its position in shares of Tempus AI by 6,247.5% in the 1st quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock worth $289,204,000 after acquiring an additional 5,900,668 shares during the period. Invesco Ltd. acquired a new stake in shares of Tempus AI during the 1st quarter worth approximately $337,000. HighTower Advisors LLC bought a new stake in shares of Tempus AI during the first quarter valued at approximately $320,000. Finally, Russell Investments Group Ltd. acquired a new position in shares of Tempus AI in the first quarter valued at $260,000. Institutional investors own 24.22% of the company’s stock.

Insider Activity

In related news, CFO James William Rogers sold 19,966 shares of the stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $73.20, for a total transaction of $1,461,511.20. Following the completion of the transaction, the chief financial officer directly owned 111,250 shares in the company, valued at approximately $8,143,500. This trade represents a 15.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Eric P. Lefkofsky sold 332,500 shares of the company’s stock in a transaction that occurred on Tuesday, October 28th. The stock was sold at an average price of $89.11, for a total value of $29,629,075.00. Following the transaction, the chief executive officer directly owned 9,074,532 shares of the company’s stock, valued at approximately $808,631,546.52. This trade represents a 3.53% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 1,097,780 shares of company stock worth $86,054,406 over the last quarter. Corporate insiders own 26.27% of the company’s stock.

Tempus AI Stock Performance

Shares of TEM stock opened at $68.67 on Tuesday. The company has a debt-to-equity ratio of 2.45, a current ratio of 3.28 and a quick ratio of 3.12. The stock has a market cap of $12.22 billion, a PE ratio of -57.71 and a beta of 5.00. The stock has a 50-day moving average of $80.48 and a 200-day moving average of $73.69. Tempus AI, Inc. has a one year low of $31.36 and a one year high of $104.32.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings data on Tuesday, November 4th. The company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.05. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. The business had revenue of $334.21 million for the quarter, compared to analyst estimates of $328.89 million. During the same quarter last year, the firm earned ($0.46) EPS. Tempus AI’s quarterly revenue was up 84.7% compared to the same quarter last year. As a group, sell-side analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on TEM shares. Morgan Stanley lifted their price target on shares of Tempus AI from $80.00 to $85.00 and gave the stock an “overweight” rating in a research note on Monday, December 1st. TD Cowen lowered shares of Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 target price on the stock. in a research report on Tuesday, October 21st. Cowen lowered shares of Tempus AI from a “buy” rating to a “hold” rating in a research report on Tuesday, October 21st. Needham & Company LLC raised their price target on shares of Tempus AI from $70.00 to $100.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Tempus AI from $85.00 to $80.00 and set a “neutral” rating on the stock in a research note on Monday. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $85.36.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.